BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22609424)

  • 1. Cardioprotection from oxidative stress in the newborn heart by activation of PPARγ is mediated by catalase.
    Chen T; Jin X; Crawford BH; Cheng H; Saafir TB; Wagner MB; Yuan Z; Ding G
    Free Radic Biol Med; 2012 Jul; 53(2):208-15. PubMed ID: 22609424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
    Sommer M; Wolf G
    Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
    Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
    Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.
    Morrison A; Yan X; Tong C; Li J
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H895-902. PubMed ID: 21666107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts.
    He H; Tao H; Xiong H; Duan SZ; McGowan FX; Mortensen RM; Balschi JA
    Toxicol Sci; 2014 Apr; 138(2):468-81. PubMed ID: 24449420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of rosiglitazone on the acid-induced intracellular generation of hydrogen peroxide in cultured feline esophageal epithelial cells.
    Park SY; Sohn UD
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Feb; 383(2):191-201. PubMed ID: 21212935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPAR gamma protects cardiomyocytes against oxidative stress and apoptosis via Bcl-2 upregulation.
    Ren Y; Sun C; Sun Y; Tan H; Wu Y; Cui B; Wu Z
    Vascul Pharmacol; 2009; 51(2-3):169-74. PubMed ID: 19540934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
    Magenta G; Borenstein X; Rolando R; Jasnis MA
    BMC Cancer; 2008 Feb; 8():47. PubMed ID: 18261208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z; Ye P; Long C; Chen K; Li X; Wang H
    Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
    Hwang J; Kleinhenz DJ; Rupnow HL; Campbell AG; Thulé PM; Sutliff RL; Hart CM
    Vascul Pharmacol; 2007 Jun; 46(6):456-62. PubMed ID: 17337254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
    Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
    Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
    Wu JS; Lin TN; Wu KK
    J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
    Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
    Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Damage to vascular endothelial cells by high insulin levels is associated with increased expression of ChemR23, and attenuated by PPAR-gamma agonist, rosiglitazone.
    Hao F; Mu JW; Zhang HJ; Kuang HY; Yu QX; Bai MM; Meng P
    Neuro Endocrinol Lett; 2015; 36(1):59-66. PubMed ID: 25789586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress.
    Martín A; Pérez-Girón JV; Hernanz R; Palacios R; Briones AM; Fortuño A; Zalba G; Salaices M; Alonso MJ
    J Hypertens; 2012 Feb; 30(2):315-26. PubMed ID: 22179086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide.
    Gonon AT; Bulhak A; Labruto F; Sjöquist PO; Pernow J
    Basic Res Cardiol; 2007 Jan; 102(1):80-9. PubMed ID: 16900441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
    Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
    Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.